Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Curr Addict Rep. 2020 Nov 12;7(4):453–463. doi: 10.1007/s40429-020-00341-9

Risks versus consequences of adolescent and young adult substance use: A focus on executive control

Monica Luciana 1
PMCID: PMC8014909  NIHMSID: NIHMS1646445  PMID: 33816055

Abstract

Purpose of review:

This review examines the role of executive control processes in the liability for substance misuse and whether substance use, once initiated, leads to subsequent decrements as proposed by neurotoxicity models of substance use disorder (SUD).

Recent findings:

As indicated by a number of recent meta-analyses, executive control processes, which include working memory, cognitive flexibility and numerous aspects of attentional, behavioral and emotional control, are impaired in the context of active SUD. Longitudinal studies of behaviorally disinhibited children, individuals with familial risks for SUD, and twins within whom genetic versus environmental influences on behavior can be modeled robustly indicate that relatively poor control is a vulnerability factor for early substance use initiation, binge patterns of use, and subsequent SUD. Evidence of further declines in executive control, once substance use is initiated, is mixed, although a growing number of neuroimaging studies indicate that frontostriatal, frontolimbic, and frontocerebellar systems are altered as a consequence of use.

Summary:

Together these patterns suggest strategies for identifying children and adolescents at high risk for SUD, avenues through which substance-related neurotoxicities can be more reliably detected, and the need to structure prevention efforts in a manner that is developmentally appropriate and perhaps personalized to individual vulnerabilities.

Keywords: executive function, adolescence, cannabis, alcohol, neurotoxicity

Introduction

Substance abuse represents a major public health problem in the United States and world-wide [1]. Earlier ages of substance use initiation, first intoxication, and binge drinking are associated with elevated risks of developing later substance use disorders (SUD) [25]. These patterns suggest that loss of control over use, especially in adolescence, represents a significant vulnerability factor for the development of problematic use patterns.

The ability to control one’s behavior is an aspect of executive function (EF), broadly defined as the ability to select, monitor and control behavior to solve novel problems and adaptively pursue long-range goals [6]. Working memory, updating, inhibitory control, and behavioral flexibility are core executive control functions [7]. These can be further parcellated into attentional, behavioral, and emotional domains [8]. Attentional control involves directing perceptual resources to stimuli that facilitate goal acquisition and disengaging attention from irrelevant or maladaptive stimuli. Behavioral control involves adjusting motor activity levels and momentary actions in response to engaging stimuli. Emotional control is the ability to regulate emotional states and arousal. Thus, adequate control includes the regulation of responses to both internal states and external stimuli [9;10]. Prudent decision-making that balances immediate motivations with longer-term goals is another marker of adequate control [11].

These various processes are enabled by overlapping neural circuits. The prefrontal cortex (PFC), through dynamic interconnections with other cortical regions, the thalamus, limbic system, and striatum acts in a supervisory manner to systematically recruit and coordinate neural circuitry in the service of goal-directed action [12]. Under demanding or stressful circumstances, the EC system can be overwhelmed [10;13] such that there are individual differences in the capacity to recruit appropriate control mechanisms but also in what it is that must be managed at any given point in time (e.g., motivational drives; objective stressors; complexity and novelty of the environment). Another factor that influences EC system integrity is its maturity [1416]. Between infancy and adulthood, the EC system becomes progressively adept at managing increasingly complex states and situations [16] but it is inconsistently recruited during adolescence [17], particularly when emotional stakes are perceived to be high [18].

A developing system is malleable. Through neurochemical and synaptic alterations [19], perturbations, such as substance use, may lead to deviant outcomes [20] including disruptions in capacities for behavioral control. It is imperative to investigate the mechanisms that underlie these dynamics given their implications for prevention efforts. The purpose of this review is to examine the role of control processes in the liability for substance misuse and whether substance use, once initiated, leads to subsequent decrements as proposed by neurotoxicity models of SUD [5].

Executive Control is Compromised in SUD

Case-control studies have demonstrated relatively worse EC functions in individuals diagnosed with SUDs. Many recent systematic reviews and 0meta-analyses have synthesized the empirical literature across hundreds of studies [2137; Table 1]. When those with SUDs, including alcohol use disorder (AUD), are aggregated and contrasted with controls, deficits are evident in working memory, cognitive flexibility, and decision-making [27]. Deficient levels of behavioral control are typically observed [30], though some analyses suggest that effect sizes are small and perhaps even negligible in cannabis [23] as well as MDMA [28] users. Decisional impulsivity, as measured through temporal discounting and risk-taking tasks [3637], is increased in most SUDs, though findings are again inconsistent for cannabis [2122;25]. When adult and adolescent cannabis users are contrasted, EF impairments are more robust in younger and heavier users [24] and in the context of more recent use [29], which might account for inconsistencies across studies. Opiate use is associated with numerous EF, decision-making, and control deficits; effect sizes for group differences appear to be consistent regardless of recency of use [36].

Table 1.

Executive control deficits in the context of active substance misuse: Reviews from 2016–2020

Authors Year of Publication Type of Paper Focus Population Findings
Biernacki, Mclennan, Terrett, Labuschagne, Rendell 2016 Meta-analysis 22 studies Decision-making in current and past opiate users relative to controls as measured by gambling, discounting, and impulsivity measures Adults Current and past users demonstrate decision-making deficits relative to controls.
Bloomfield, Hindocha, Green, Wall, Lees et al. 2019 Review Human neuroimaging studies of cannabis use; acute and chronic effects Cannabis use can alter neural circuitry, subvert the reward system, and interfere with executive functions; numerous neurochemical systems are involved in these effects including endocannabinoid, dopamine, glutamate and GABA systems
Broyd, van Hell, Beale, Yucel, Solowij 2016 Systematic Review 105 studies Cognition in acute and chronic cannabis use All ages Verbal learning, memory and attention impaired by acute and chronic use; mixed evidence for impaired EF and decision-making
Chen, Yang, Chen, Su, Jiang, Zhao 2020 Meta-analysis and meta-regression 52 studies Risky decision-making in all classes of SUD Adolescents and adults Increased risky-decision making in all SUD except for cannabis and amphetamine-like stimulants; evidence for worse impairment with increasing age
Chye, Christensen, Yucel 2020 Review 43 adolescent studies 20 adult studies Structural and functional neuroimaging studies of cannabis use in adolescents Adolescents Case-control comparisons primarily implicate frontal and parietal regions when inhibitory control, memory, or reward processing was required.
Figueiredo. Tolomeo, Steele, Baldacchino 2020 Systematic Review and Meta-Analysis 13 studies Neurocognition in chronic cannabis use All ages Cannabis users show deficits in cognitive flexibility, cognitive impulsivity, attention, short-term memory and long-term memory; no evicence of deficits in motor impulsivity
Gorey, Kuhns, Smaragdi, Kroon, Cousijn 2019 Systematic Review 21 studies Age differences in impacts of cannabis on cognition Contrast of adolescent vs. adult animals and humans Executive functions more impaired in adolescent frequent cannabis users vs. adult cannabis users; age effects strongest in heavy dependent users
Lovell, Akhurst, Padgett, Garry, Matthews 2019 Meta-analysis 30 studies Cognitive outcomes in long-term regular recreational cannabis use Adults Cannabis was associated with small-magnitude deficits in executive function, learning and memory, and global cognition; there were moderate deficits in decision making Non-significant effects were noted for working memory and attention.
Mahoney, Bryant, Haut 2019 Review Cognition, emotional health, and neural findings with abuse of opiates, alcohol, stimulants, cannabis, benzodiazapines, synthetics, or hallucinogens All ages but primarily studies of adults Most substances of abuse are associated with frontal impairments; neural structures implicated include the PFC, striatum, and interconnecting pathways
Ramy, Regier 2019 Review Cognition in SUD with a focus on EF, precognition and social cognition Adults EF deficits are consistently observed in SUD and may represent intermediate phenotypes; precognitive and metacognitive processes may anchor these findings
Roberts Jones, Montgomery 2016 Meta-analysis 39 studies Executive functions in polydrug/MDMA users Adults MDMA users demonstrate executive dysfunction when findings aggregated across tasks; deficits are most pronounced for attention, cognitive flexibility, and updating; no deficits in inhibitory control
Scott, Slomiak, Jones, Adon, Rosen, Moore, Gur 2018 Meta-analysis 69 studies Cognition and cannabis use Adolescents and young adults Significant effect sizes for learning, executive function (including inhibitory control), delayed memory and attention; longer abstinence periods associated with decreased effect sizes; no differences in effect size by age or by age of cannabis use initiation
Stephan, Alhassoon, Allen, Wollman, Hall, et al. 2016 Meta-analysis 77 studies Clinical neuropsychological findings of executive dysfunction in alcohol use disorder Adults Planning, problem solving and inhibitory control are significantly impacted by AUD; effect sizes were strongest for decisional and cognitive impulsivity
Sullivan, Pfefferbaum 2019 Review Effects of aging and comorbidities on deficits observed in alcohol use disorder (AUD) Adults Frontostriatal, frontocerebellar and frontolimbic network functions are compromised in AUD; executive functions and motivation are impacted
Tervo-Clemmens, Quach, Calabro, Foran, Luna 2020 Meta-analysis and review 22 studies Functional neuroimaging studies relevant to adolescent substance use Adolescence The reviewed studies were most relevant to SUD vulnerability and showed activation differences in the striatum, versus PFC, in high risk youth.
Verdejo-Garcia 2017 Review Executive function in all classes of chronic substance use All ages EF deficits observed in all classes of SUD but to varying degrees; deficits in decision-making are common
Zilverstand, Huang, Alia-Klein, Goldstein 2018 Systematic Review 105 studies Neuroimaging evidence of impaired response inhibition and salience attribution in drug addiction Adolescents and Adults Six brain networks were implicated in SUD across tasks: the reward, habit, salience, and executive networks as well as two additional networks devoted to self-directed behavior and memory, respectively

Much of this literature focuses on cognitive and behavioral control. However, individuals with SUDs also exhibit biases in attentional control, such that they are primed to detect substance-related stimuli relative to other cues [38]. Moreover, they may show emotion dysregulation [39] and susceptibility to negative affect under stressful circumstances. Dual diagnoses are common and associated with EF impairments [40]. These patterns are indicative of EC weaknesses when demands intensify.

Reviews of findings from neuroimaging studies cohere in suggesting that frontostriatal, frontolimbic, and frontocerebellar networks are compromised in SUDs, underpinning deficits in cognitive, behavioral, and emotional control [26;3135]. Because findings are largely similar for various substances of abuse and when individuals with varied drug preferences are combined and contrasted with non-users, it appears that aberrant patterns of EC are manifested transdiagnostically.

Many extant studies captured case-control differences through single assessments and after SUDs were well-established raising questions about whether deficient EC is caused by substance use. Alternatively, individuals with poor EC may be more likely to experiment with substances due to impulsivity and may initiate use at an early age. They might also experience liabilities such as lack of parental support and academic difficulties [41]. Vulnerability or risk models propose that premorbid differences explain the EC deficits observed in SUD. Distinctions attributable to premorbid vulnerability versus neurotoxicity, which can be discerned through longitudinal modeling, are important to establish, because prevention efforts and their timing will vary depending on which process is targeted.

Poor Executive Control is a Vulnerability Factor for Substance Misuse

To address this question, EC must be reliably measured across the lifespan. Laboratory measures are not easily or even routinely implemented prior to school age. However, difficulties with attention regulation, inhibitory control and emotional stability often co-occur within individuals, characterizing what has been termed behavioral disinhibition, undercontrol or externalizing [42]. Disinhibition, conceptualized as a coherent dimension of behavior, is manifested by high activity levels observed as early as infancy, irritability/aggression, impulsivity, as well as symptoms of attention-deficit hyperactivity disorder (ADHD), oppositional-defiant disorder, antisocial behavior, and substance misuse. Whether behavioral disinhibition is fully synonymous with deficient EC as typically measured in the laboratory is debated. Evidence is accumulating in support of an overlap in the constructs [4345].

Across measures, three types of studies support vulnerability models to explain the EC deficits observed with substance misuse: (1) those that follow behaviorally disinhibited children from an early age into the initiation and progression of substance use; (2) family studies indicating that those at high familial risk for SUD have poor EC and/or high levels of behavioral disinhibition prior to SUD onset; (3) longitudinal twin studies that quantitatively model genetic versus environmental sources of variation in the covariance among behavioral disinhibition, executive control, and substance use.

Behavioral Disinhibition and Substance Use Involvement

Individuals with high childhood levels of impulsivity/disinhibition are more likely to initiate substance use and to experience problematic use [46]. Data from epidemiologically-informed samples followed from early childhood into adulthood cohere in suggesting that preschoolers with low levels of behavioral control have earlier substance use initiation and more problematic use by early adulthood [4748]. Recently, Meier et al [49] analyzed data from a representative cohort of 1,037 individuals born in Dunedin, New Zealand and followed prospectively to age 38. A set of nine pre-adulthood risk factors were used to predict persistent substance dependence in adulthood with high accuracy. Childhood conduct disorder symptoms were among the strongest early life predictors of later disorder. Similarly, children diagnosed with ADHD, studied as part of the International Multicenter ADHD Genetics study, were more likely to develop adult SUD [50]. Zellers et al. [51] incorporated a biometric latent growth model of marijuana use frequency across five assessment waves in two samples of twins spanning ages 14 to 30. Adolescent externalizing psychopathology was genetically associated with young adult increases in marijuana use and with maintenance of use over time. Furthermore, a recent longitudinal study of over 800 U.S. high school students studied between ages 16 and 30 found that externalizing but not internalizing symptomatology predicted adult AUD [52).

Lab measures of EC yield similar findings. In a cross-sectional survey of over 1500 nine year-olds, low levels of self-reported EF were associated with higher levels of lifetime substance use [53], despite substance use being relatively rare in this age group. Similar associations in in relation to working memory performance are evident [54]. Peeters and colleagues [55] examined two EF domains, working memory and inhibitory control, in a high risk sample of over 500 12–15 year-olds in the Netherlands and found through a survival analysis that relatively weak working memory, measured by a self-ordered pointing task, predicted both the initiation of the first alcoholic drink and the first binge drinking episode, above and beyond the effect of response inhibition, which also predicted drinking initiation. Recent cross-sectional examinations of participants (n = 817; ages 12 through 21) in the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study found that executive dysfunction, including performance on a delay discounting measure of cognitive impulsivity, was significantly related to both risky alcohol and cannabis use [5657]. Finally, Jones et al [58] followed substance naïve adolescents (n=249) into the adult initiation of substance use, reporting that trait measures of impulsivity as well as laboratory behavioral control tasks, predicted later drinking behavior (maximum drinks in a day, heavy episodic drinking, alcohol-related problems).

Interactions between EC vulnerabilities and motivational tone appear likely: Using a longitudinal design, Peeters et al. [59] found that adolescent drinkers with poor inhibitory control showed stronger approach tendencies and attentional biases toward alcohol cues compared to those with better inhibitory skills. They also demonstrated greater alcohol use over a six-month follow-up period. More recently, Kim-Spoon et al. [60] demonstrated that high levels of self-reported behavioral activation (e.g., reward sensitivity) predicted an earlier onset of substance use among adolescents with low, but not high, inhibitory control. Strickhouser et al. [61] reported that among a large nationally representative sample of Australian children, high sociability levels in early childhood predicted adolescent substance use initiation, while trait levels of persistence were protective. Accordingly, those with strong motivational drives as well as low capacities for control, which combine to challenge the EC system, are particularly vulnerable to impulsivity and substance misuse.

In support of these behavioral findings, an increasing number of neuroimaging studies indicate that the neural circuitry underpinning EC is compromised prior to substance use initiation. Blunted patterns of neural activation in regions such as the middle frontal gyrus, striatum, and inferior parietal cortex, which mediate inhibitory control have been observed [6263]. These findings cohere with findings of similar deviations in individuals with severe SUD [64]. Variations in striatal activation were implicated in a recent meta-analytic study of adolescents vulnerable to SUD on the basis of externalizing tendencies and positive family histories [45]. In addition to deviations within cognitive control circuitry, recent work also suggests heightened reward system activation in individuals vulnerable to later substance misuse [63], although prospective work involving substance naïve individuals is needed.

In summary, youth with higher trait levels of disinhibitory behaviors as well as relatively poor executive control as measured by behavioral and imaging probes are more likely to engage in substance use at an early age (when the brain is still developing), to use heavily, and to later experience fully syndromic patterns of SUD. Predictive associations are inconsistent or negligible for other forms of behavioral dysregulation, such as internalizing tendencies [52].

Family studies

A parallel line of work has focused on children, adolescents and young adults at high risk for SUD based on positive family histories [65]. AUD has been a typical focus of such studies. Its prevalence is higher in those with positive parental histories, a pattern that may be mediated, in part, by genetically-transmitted trait levels of disinhibition and hence, low levels of EC [66]. Individuals with positive family histories of SUD demonstrate increased sensation-seeking, impulsivity, and other disinhibitory traits [39, 6668] as well as relatively low scores on EF measures in childhood and adolescence, even prior to the onset of substance use [68]. They are more likely to initiate substance use at an early age and are more likely to show associations between baseline EF and subsequent substance use. These associations may be mediated by temperamental traits or adverse life events [68].

Brain mechanisms that contribute to these effects have been described [6974]. A meta-analysis focused on the electrophysiologically-derived P300 waveform, a potential endophenotypic marker of liability to disinhibition, indicated significant reductions in SUD, particularly in males with positive family histories [72]. Using brain MRI techniques, DeVito and colleagues [69] contrasted family-history positive and negative adults in fMRI go/no-go task performance, impulsivity and alcohol use. Family history positive individuals showed greater activation in the left anterior insula and inferior frontal gyrus during successful inhibitions, an effect that was found primarily in males. Another study [70] used diffusion-weighted imaging and voxel-wise multilevel modeling to assess white matter microstructural development in 45 substance naïve adolescents, who subsequently engaged in binge-drinking, and 68 adolescents, who remained largely abstinent, all with varying degrees of familial AUD. Deviations in frontostriatal white matter microstructure were evident early in adolescence, prior to alcohol use, as a function of both future binge drinking and family history. Numerous other neuroimaging studies demonstrate similar structural and functional neural deviations in family history positive individuals [71; 73]. A recent large-scale study of 6898 youth enrolled in the Adolescent Brain Cognitive Development (ABCD) Consortium study examined neural activation during the Stop Signal Task, which demands response inhibition, in substance-naïve youth aged 9 to 10 years with and without parental AUD histories. Greater levels of neural activation in frontostriatal and cerebellar networks were observed in family history positive youth [74].

In summary, behavioral studies of family history positive individuals support that relative impairments in executive control represent a liability for early substance use initiation and later substance use problems. Across MRI studies, the direction of effects (e.g., higher versus lower levels of BOLD activations and structural anomalies) varies, perhaps due to developmental timing, task variations or other individual difference factors.

Longitudinal Twin Studies

Behavior genetic studies provide a unique opportunity to use quantitative modeling of genetic similarities to assess covariance between executive function and substance use and whether shared variance between the two is due to genetic similarity or to environmental influences. Twin and family study paradigms have consistently affirmed that SUDs are highly heritable [75]. Using structural equation modeling, it has been demonstrated across laboratories that the latent factor of behavioral disinhibition is also heritable [76] as are individual variations in a common executive function factor [77] and specific EF measures, such as delay discounting [78]. In a recent study, Gustavson et al. [79], analyzed data from 850 twins enrolled in the Colorado twin registry, examining associations between numerous facets of executive control, including a common factor, and substance use characteristics in adolescents studied longitudinally at age 17 and again at age 23. Higher EF levels in adolescence, but not adulthood, were associated with lower substance use frequencies and lower numbers of substances ever used. Twin analyses indicated that these associations were genetic in origin.

In summary, there is compelling highly replicated evidence from a variety of paradigms that a low level of executive control, whether reflected through behavioral disinhibition, decreased performance on discrete EF tasks, or altered patterns of relevant neural structure and function represents a premorbid genetically-influenced vulnerability for later substance use problems.

Neurotoxicity: Does EF decline after substance use initiation?

These patterns raise the question of whether executive control further declines from premorbid levels after substance use initiation onset and as symptoms of SUD emerge. At theoretical, preclinical, and anecdotal levels, there is ample reason to expect a decline. Many substances, particularly alcohol, methamphetamine, and MDMA, are neurotoxic: neuronal integrity and the functional connectivity of neural circuitry is compromised with heavy use [31; 8081]. SUD is, by definition, characterized by a loss of behavioral and emotional control [82]. Due to neuroplastic changes in neurochemical systems that mediate responses to positive reinforcers, sensitivity to rewards other than the substance itself is diminished. Use becomes increasingly compulsive as neural processing is altered in favor of habit-based systems, mediated by dorsal striatal circuitry. Allostatic changes are observed in striatal and limbic circuits as addiction progresses from the initial binging stage, to loss of control over use, to maintenance of use by negative reinforcement. These changes are well-documented in animals [19; 83].

Because executive control is already compromised prior to SUD in at-risk individuals, it is challenging in the midst of addiction to further achieve control over increasingly strong impulses to continue use. This difficulty is exacerbated by withdrawal symptoms and the accompanying negative affect that emerges with acute and and longer-term abstinence. These conditions create ongoing demands for emotional regulation [83].

However, beyond this loss of control over substance-seeking behavior, relatively few studies have demonstrated addiction-related decrements in discrete laboratory-measured EFs. Animal studies provide evidence of allostatic changes in prefrontal neurochemistry, particularly within glutamatergic systems and following psychostimulant administration [8485]. There are covarying declines in working memory function limited to high load conditions [84]. Yet, a recent critical review of the human literature found limited evidence of working memory decrements following cocaine administration [86].

In contrast, Paige and Colder [87] assessed a community sample of 387 adolescents who completed nine annual assessments starting at ages 11–12. Attentional and inhibitory control were assessed with temperament inventories. Structural equation modeling indicated that those who engaged in heavy marijuana use at ages 12–14 had low levels of attentional control at ages 18–21, above and beyond baseline levels. In support of this finding, a recent review of longitudinal neuropsychological studies [88] concluded that cannabis use is associated with neuropsychological declines. However, these associations were modest in size, raising questions about clinical significance. Functional declines were most evident in those with the heaviest cannabis use and were often dramatically attenuated after controlling for confounding variables. Despite this trend, some longitudinal studies of heavy users have failed to observe behavioral decrements over time in the context of continued use [8990]. For instance, Becker et al. [89] followed daily cannabis users across a two-year period finding that while verbal learning and memory were persistently impaired over time in users relative to controls, no new deficits emerged.

Similarly, longitudinal twin studies have failed to observe cannabis-related declines in cognitive functions, including EC. Ross et al [91], leveraging data from the Colorado twin study, used a quasi-experimental co-twin control design to test impacts of cannabis use on executive functions, finding little evidence in support of cannabis-induced decrements. Only one association among 70 that were examined--an association between cannabis use frequency at age 17 and worse performance on a metric representing common executive function at age 23—was observed.

Recently, Khurana et al. [92] assessed a community sample of 387 adolescents annually over five consecutive years on a behavioral battery that included working memory tests, delay discounting, and impulsivity measures. Baseline weaknesses in working memory, in association with a measure of acting without thinking, was a significant predictor of later SUD. Working memory predicted SUD both independent of early drug use and as mediated by early drug use progression, consistent with vulnerability models. Variations in substance use over time were not associated with worsening of working memory. Concordantly, using data from the Tracking Adolescents’ Individual Lives Survey (TRAILS) [93], the maturation of executive functioning was assessed in a cohort of 2230 Dutch adolescents within four domains (inhibition, working memory, and shift- and sustained attention) between ages 11 and 19. There were no differences in cognitive maturation in relation to levels of alcohol use involvement, including chronic heavy drinking behavior.

Some studies have been more suggestive regarding post-substance-use alterations in EC functions and indeed have suggested distinct ways in which such effects might manifest themselves. Wilson et. al. [54] examined developmental trajectories of multiple indicators of behavioral inhibition in 1512 twins from the Minnesota Center for Twin Research who were studied at ages 11, 14, 17, 20, and 24. Those who developed SUDs were characterized by low premorbid levels of visuospatial attention and working memory and stable high levels of behavioral disinhibition indexed by questionnaire measures, consistent with other reports. Deviant developmental trajectories were also observed for a lab-based measure of inhibitory control, suggesting that in adolescents, a “decline” in EC functions may be observed as a failure to reach expected developmental levels.

Developmental delays are difficult to assess, because age-scaled norms do not exist for EC measures commonly utilized in laboratory settings, individual variation is high, and sample sizes are often small, limiting the ability to detect developmental differences. More generally, human studies have not been optimized to assess the impacts of premorbid executive dysfunction as well as the effect of substances on the same cognitive measures pre-and post-use. Inconsistencies across studies could also be driven by individual differences in cognitive reserve, the extent to which compensatory processes can be recruited, in the context of some prior insult, to achieve task success. A related construct, brain reserve, refers to compensatory flexibility within neural circuits [94]. Reserve is thought to be relatively high in youth. It may be that behavioral function is largely intact early in the course of substance misuse while brain reserve is diminished. Concordantly, several studies have reported deviations from expected patterns of neurodevelopment in youth who transition from being substance naïve into moderate-to-heavy substance use [c.f., 9597;98].

A recent longitudinal analysis focused on a large number of adolescent participants in the NCANDA Consortium study found that youth who initiated heavy drinking, exhibited an accelerated rate of frontal lobe gray matter decline [96] as well as deviations in cerebellar growth over time [97]. Alcohol dependent adults also show anomalies in the cerebellum as well as regions associated with executive control. They exhibit EF deficits that resemble patterns observed with accelerated aging [31]. Thus, it may be that in younger individuals, neuroplastic alterations that deviate from expected neurodevelopmental changes can be detected early in the course of substance use. These alterations may serve to maintain normative levels of behavior.

These findings must be interpreted with caution given that Robert et al. [98] using recent longitudinal data from adolescents enrolled in the IMAGEN Consortium found that longitudinal increases in drunkenness frequency were associated with accelerated gray matter atrophy in the left posterior temporal cortex, right posterior temporal cortex, and left prefrontal cortex. However, causal bayesian network analyses suggested that these patterns were driven by premorbid liabilities.

Some cross-sectional studies and a select number of longitudinal studies have reported dose-outcome effects, which broadly support neuroplastic effects. Earlier ages of substance use onset have been inconsistently associated with worse EF and/or deviant patterns of neurodevelopment perhaps indicating that substance use is more detrimental to brain development when the substance is introduced earlier in the adolescent neurodevelopmental sequence. However, as noted in several recent reviews [29; 46; 99], associations between substance use patterns (age of onset, duration of use and other proxies for dose effects) and behavioral disinhibition are not reliably observed.

Conclusions, future directions and implications for prevention efforts

Evidence strongly suggests that deficient EC is a premorbid individual differences factor that is genetically transmitted and renders some individuals particularly vulnerable to early experimentation with substances. Yet, despite evidence of allostatic changes associated with drugs of abuse as well as ample evidence of loss of control over responses to the abused substance in addiction, longitudinal impacts on cognition, as measured by laboratory-based executive control tasks, have not been consistently demonstrated. This limitation is attributable, in part, to the relative lack of studies that have followed sufficient numbers of youth from pre-initiation into the development of the addiction syndrome and limitations imposed by typical measurement strategies.

In contrast, an increasing number of developmental imaging studies support the idea that neural structure, structural connectivity, and functional activation within regions and circuits that underpin executive control show deviations in expected developmental trajectories within 1–2 years following alcohol use initiation that persist after cessation of use [99]. Findings are mixed for cannabis use. This area of inquiry will benefit from studies such as NCANDA [100], ABCD [101], and the planned Healthy Brain and Child Development (hBCD) study, https://heal.nih.gov/research/infants-andchildren/healthy-brain, which are large-scale longitudinal developmental neuroimaging investigations supported by the National Institutes of Health, poised to disentangle premorbid influences on substance use initiation from substance-related effects. Thousands of children from demographically diverse backgrounds, including twins, are being followed from substance-naïve periods of childhood, through adolescence and into young adulthood.

To the extent that these studies can be methodologically harmonized with epidemiological investigations underway worldwide [98; 102], cross-cultural norms can be gathered for measures of executive control. Such measures are rarely harmonized across studies and laboratories, although there is some consistency regarding which specific tasks tend to yield significant effects, e.g. self-ordered pointing assessments of working memory [55; 92] and temporal discounting measures [37; 56; 68]. Similarly, the field lacks comprehensive norms for metrics such as regional brain volumes as well as the magnitudes and timing of neurodevelopmental shifts. Not all statistical deviations are clinically significant, and normative data would provide a means of mapping individual performance variations onto typical developmental trajectories.

A thesis of this review is that adolescents and young adults are sensitive to increasing information processing loads (e.g., conditions that demand the simultaneous recruitment of attentional, emotional, and cognitive control processes) as executive control processes reach maturity [16; 83]. Sensitive behavioral measures, administered under conditions of experimentally-induced high demand, are not routinely utilized but may be needed to detect post-initiation impacts of substance use on executive control.

Prevention efforts remain vital to safeguard vulnerable individuals from later SUD and to circumvent brain-based alterations that may provoke a cascade of behavioral effects that manifest at later points in time. Executive control is increasingly conceptualized as a malleable aspect of behavior, amenable to training, and heavily influenced by context [103]. Consistent with other frameworks [104], this review emphasizes that not all adolescents are at equivalent risk for substance misuse. Because disinhibited children can be identified early relative to their peers, personalized prevention efforts can be instituted in early childhood and at intervals thereafter, perhaps corresponding to ages when expected accelerations in executive function occur. Except in the most impaired individuals, executive control is readily achieved when task demands are low and more challenging under conditions where cognitive load is high, perceived stress is extreme, and emotions are salient. Thus, interventions might focus on ways to diminish demanding internal and environmental sources of burden, for instance by encouraging increased deliberation in the context of momentary decision-making, stress reduction techniques, and attempts to direct reward strivings in adaptive versus maladaptive ways. If transitions from experimentation to addiction can be examined in a more fine-grained manner through frequent longitudinal assessments, other developmentally-appropriate prevention strategies that leverage both individual strengths but also weaknesses in executive control may become evident.

Acknowledgments

This work was supported by National Institutes of Health grants U01DA041120 and R56MH122473. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.

Funding: The author’s work on this review paper was supported by National Institutes of Health grants U01DA041120 and R56MH122473.

Footnotes

Conflicts of interest/Competing interests: The author has no conflicts of interest to disclose.

Declarations:

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  • 1.Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al. Trends and patterns of geographic variation in mortality from substance use disorders and intentional injuries among US counties, 1980–2014. JAMA. 2018; 319:1013–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cogn Neurosci. 2017; 25:29–44 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.SAMHSA, 2019. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health (HHS Publication No. SMA 18–5068, NSDUH Series H-53). Rockville, MD.: Substance Abuse and Mental Health Services Administration. 2018: Retrieved from. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf. [Google Scholar]
  • 4.Newton-Howes G, Cook S, Martin G, Foulds JA, Boden JM. Comparison of age of first drink and age of first intoxication as predictors of substance use and mental health problems in adulthood. Drug and Alcohol Dependence. 2018; doi: 10.1016/j.drugalcdep.2018.10.012 [DOI] [PubMed] [Google Scholar]
  • 5.Jacobus J, Tapert SF: Neurotoxic effects of alcohol in adolescence. Annu Rev Clin Psychol 2013; 9:703–721 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Stuss DT. Functions of the frontal lobes: relation to executive functions. Psychological Research. J Int Neuropsychol Soc. 2011;17(5):759–65. [DOI] [PubMed] [Google Scholar]
  • 7.Friedman NP, Miyake A Unity and diversity of executive functions: Individual differences as a window on cognitive structure. Cortex. 2017; 86: 186–204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nelson TD, Mason A, Nelson JM. Executive control and adolescent health: Toward a conceptual framework. Adolescent Research Review.2019; 4:31–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Luciana M Executive function in adolescence: A Commentary on regulatory control and depression in adolescents: Findings from neuroimaging and neuropsychological research. Journal of Clinical Child & Adolescent Psychology. 2016; 45 (1): 84–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zainal NH, Newman MG. Within-person increase in pathological worry predicts future depletion of unique executive functioning domains. Psychological Medicine. 2020: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Verbruggen F Executive control of actions across time and space Curr. Dir. Psychol. Sci. 2016; 25: 399–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McTeague LM, Huemer J, Carreon DM, Jiang Y, Eickhoff SB, Etkin A. Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. Am J Psychiatry. 2017;174:676–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schmeichel BJ. Attention control, memory updating and emotion regulation temporarily reduce the capacity for executive control. Journal of Experimental Psychology: General. 2017; 136(2): 241–255. [DOI] [PubMed] [Google Scholar]
  • 14.Fiske A, Holmboe K. Neural substrates of early executive function development. Dev. Rev. 2019; 52:42–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Best JR, Miller PH. A developmental perspective on executive function. Child Development. 2010; 81(6): 1641–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Luciana M, Conklin HM, Hooper CJ, Yarger RS. The development of nonverbal working memory and executive control processes in adolescents. Child Development. 2005; 76(3): 697–712. [DOI] [PubMed] [Google Scholar]
  • 17.Luna B, Padmanabhan A, O’Hearn K. What has fMRI told us about the development of cognitive control through adolescence? Brain and Cognition. 2010; 72: 101–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Breiner K et al. Combined effects of peer presence, social cues, and rewards on cognitive control in adolescents Dev. Psychobiol. 2018; 60: 292–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Koob GF, Volkow ND. Neurobiology of addiction: A neurocircuitry analysis. Lancet Psychiatry, 2016; 3(8): 760–773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Selemon LD. A role for synaptic plasticity in the adolescent development of executive function. Translational Psychiatry. 2013; 3(3): e238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry. 2016;79:557–67. [DOI] [PubMed] [Google Scholar]
  • 22.Chen S, Yang P, Chen T, Su H, Jiang H, Zhao M Risky decision-making in individuals with substance use disorder: A meta-analysis and meta-regression review. Psychopharmacology. 2020; 10.1007/s00213-020-05506-y. [DOI] [PubMed] [Google Scholar]
  • 23.Figueiredo PR, Tolomeo S, Steele JD, Baldacchino A Neurocognitive consequences of chronic cannabis use: A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2020; 108: 358–369 [DOI] [PubMed] [Google Scholar]
  • 24.Gorey C, Kuhns L, Smaragdi E, Kroon E, Cousijn J. Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review. Eur Arch Psychiatry Clin Neurosci. 2019; 10:15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lovell ME, Akhurst J, Padgett C, Garry MI, Matthews A Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis. Experimental and Clinical Psychopharmacology, 2019; 10.1037/pha0000326 [DOI] [PubMed] [Google Scholar]
  • 26.Mahoney JJ, Bryant KR, Haut MW. Substance use disorders: Cognitive sequelae, behavioral manifestations, neuroimaging correlates and novel interventions. In Armstrong CL, Morrow LA, Editors: Handbook of Medical Neuropsychology: Applications of Cognitive Neuroscience. Springer Nature. 2019; 697–726. [Google Scholar]
  • 27.Ramy T, Regier PS. Cognitive impairment in substance use disorders. CNS Spectrums. 2019; 24:102–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Roberts CA, Jones A, Montgomery C Meta-analysis of executive functioning in ecstasy/polydrug users. Psychological Medicine. 2016; 46(8):1581–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Scott JC, Slomiak ST, Jones JD, Rosen AF, Moore RM, Gur RC. Association of cannabis with cognitive functioning in adolescents and young adults: A systematic review and meta-analysis JAMA Psychiatry. 2018; 75: 585–595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Stephan RA, Alhassoon OM, Allen KE, Wollman SC, Hall M, Thomas WJ…Grant I Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder. American Journal of Drug and Alcohol Abuse. 2016; 12: 1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sullivan EV, Pfefferbaum A Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review. Neuropsychology. 2019; 33(6): 760–780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tervo-Clemmens B, Quach A, Calabro FJ, Foran W, Luna B. Meta-analysis and review of functional neuroimaging differences underlying adolescent vulnerability to substance use. Neuro Image. 2020; 209:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bloomfield MAP, Hindocha C, Green SF, Wall MB, Lees R, Petrilli K, … Freeman TP. The neuropsychopharmacology of cannabis: A review of human imaging studies. Pharmacology and Therapeutics. 2019; 195: 132–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chye Y, Christensen E, Yucel M Cannabis use in adolescence: a review of neuroimaging findings. J. Dual Diagn. 2020; 10.1080/15504263.15502019.11636171. [DOI] [PubMed] [Google Scholar]
  • 35.Zilverstand A, Parvaz MA, Goldstein RZ. Neuroimaging cognitive reappraisal in clinical populations to define neural targets for enhancing emotion regulation. A systematic review. Neuroimage. 2017;151: 105–116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Biernacki K,Mclennan SN, Terrett G, Labuschagne I, Rendell PG. Decision-making ability in current and past users of opiates: a meta-analysis. Neurosci Biobehav Rev. 2016; 71:342–351 [DOI] [PubMed] [Google Scholar]
  • 37.Verdejo-Garcia A Executive dysfunction in addiction. In Goldberg E (Ed): Executive Functions in Health and Disease. Elsevier. 2017; 10.1016/B978-0-12-803676-1.00016-7: 395–403. [DOI] [Google Scholar]
  • 38.Anderson BA. What is abnormal about addiction-related attentional biases? Drug Alcohol Depend. 2016; 167: 8–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Haeny AM, Gueorguieva R, Morean ME, Krishnan Sarin S, DeMartini KS, Pearlson GD …, O’Malley SS. The association of impulsivity and family history of alcohol use disorder on alcohol use and consequences. Alcohol Clin Exp Res. 2020; 44 (1): 159–167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Duijkers JCLM, Vissers CTWM, Egger JIM. Unraveling executive functioning in dual diagnosis. Frontiers in Psychology. 2016; 7: 979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wills TA, Simons JS, Sussman S, Knight R Emotional self-control and dysregulation: A dual-process analysis of pathways to externalizing/internalizing symptomatology and positive well-being in younger adolescents. Drug Alcohol Depend. 2016; 163(Suppl 1): S37–S45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Windle M Behavioral Undercontrol: A Multifaceted Concept and Its Relationship to Alcohol and Substance Use Disorders. In Zucker RA, Brown SA, Editors: Oxford Handbook of Adolescent Substance Use Disorders. Oxford University Press; 2019. [Google Scholar]
  • 43.Venables NC, Foell J, Yancey JR, Kane MJ, Engle RW, Patrick CJ. Quantifying inhibitory control as externalizing proneness: A cross-domain model. Clinical Psychological Science. 2018; 6(4): 561–580. [Google Scholar]
  • 44.Huang-Pollock C, Shapiro Z, Galloway-Long H, Weigard A Is poor working memory a transdiagnostic risk factor for psychopathology? Journal of Abnormal Child Psychology. 2017; 45: 1477–1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Tervo-Clemmens B, Quach A, Luna B, Foran W, Chung T, DeBellis MD, Clark DB.. Neural correlates of rewarded response inhibition in youth at risk for problematic alcohol use. Frontiers in Behavioral Neuroscience. 2017; 11:205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Verdejo-García A, Lawrence AJ, Clark L Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 2008; 32: 777–810. [DOI] [PubMed] [Google Scholar]
  • 47.McGue M, Iacono WG, Legrand LN, Elkins I The origins and consequences of age at first drink. I. Associations with substance-use disorders, disinhibitory behavior and psychopathology, and P3 amplitude. Alcoholism: Clinical and Experimental Research. 2001; 25(8): 1156–65. [PubMed] [Google Scholar]
  • 48.Dick DM, Aliev F, Latendresse SJ, Hickman M, Heron J, Macleod J, Joinson C, Maughan B, Lewis G, Kendler KS. Adolescent alcohol use is predicted by childhood temperament factors before age 5, with mediation through personality and peers. Alcoholism: Clinical and Experimental Research. 2013; 37(12):2108–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Meier MH, Hall W, Caspi A, Belsky DW, Cerda M, Harrington HL et al. Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. 2016; 46(4): 877–889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Groenman A, Oosterlaan J, Greven C, Jelle Vuijk P, Rommelse N, Franke B … Buitelaar J. Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up. Journal of Child Psychology and Psychiatry. 2015; 56(5): 521–529. [DOI] [PubMed] [Google Scholar]
  • 51.Zellers SM, Corley R, Thibodeau E, Kirkpatrick R, Elkins I, Iacono WG. et al. Adolescent externalizing psychopathology and its prospective relationship to marijuana use development from age 14 to 30: Replication across independent longitudinal twin samples. Behavior Genetics. 2020; 50: 139–151.* This important study utilized two independent twin samples and state-of-the-art statistical modeling to demonstrate that externalizing psychopathology in adolescence is genetically correlated with changes in late adolescent marijuana use and with maintenance of use in young adulthood.
  • 52.Farmer RF, Gau JM, Seeley JR, Kosty DB, Sher KJ, Lewinsohn PM. Internalizing and externalizing disorders as predictors of alcohol use disorder onset during three developmental periods. Drug Alcohol Depend. 2016; 164: 38–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Pentz MA, Shin H, Riggs N, Unger J, Collison K, Chou C Parent, peer, and executive function relationships to early adolescent e-cigarette use: a substance use pathway? Addictive Behaviors. 2015; 42: 73–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wilson S, Malone SM, Venables NC, McGue M, Iacono WG. Multimodal indicators of risk for and consequences of substance use disorders: Executive functions and trait dysconstraint assessed from preadolescence into early adulthood. International J. of Psychophysiology. 2019; 10.1016/j.ijpsycho.2019.12.007.* This study incorporated a multimodal assessment of disinhibition and followed children from preadolescence into young adulthood, finding that low levels of constraint and working memory were premorbid risk factors for later substance misuse. An important finding was that those who engaged in later substance use showed deviant trajectories in the development of laboratory-measured inhibitory control.
  • 55.Peeters M, Janssen T, Monshouwer K, Boendermaker W, Pronk T Weaknesses in executive functioning predict the initiating of adolescents’ alcohol use. Developmental Cognitive Neuroscience. 2015; 16: 139–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sullivan EV, Brumback T, Tapert SF, Fama R, Prouty D, Brown SA, Cummins K, Thompson WK, Colrain IM, Baker FC, De Bellis MD, Hooper SR, Clark DB, Chung T, Nagel BJ, Nichols BN, Rohlfing T, Chu W, Pohl KM, Pfefferbaum A. Cognitive, emotion control, and motor performance of adolescents in the NCANDA study: Contributions from alcohol consumption, age, sex, ethnicity, and family history of addiction. Neuropsychology. 2016; 30:449–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Clark DB, Chung T, Martin CS, Hasler BP, Fitzgerald DH, Luna B, Brown SA, Tapert SF, Brumback T, Cummins K, Pfefferbaum A, Sullivan EV, Pohl KM, Colrain IM, Baker FC, De Bellis MD, Nooner KB, Nagel BJ. Adolescent executive dysfunction in daily Life: Relationships to risks, brain structure and substance use. Frontiers in Behavioral Neuroscience. 2017; 11:223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Jones CB, Meier MH, Corbin WE, & Chassin L Adolescent executive cognitive functioning and trait impulsivity as predictors of young-adult risky drinking and alcohol-related problems. Psychology of Addictive Behaviors. 2020; Advance online publication. 10.1037/adb0000636 [DOI] [PubMed] [Google Scholar]
  • 59.Peeters M, Monshouwer K, Schoot RA, Janssen T, Vollebergh WAM, & Wiers RW. Automatic processes and the drinking behavior in early adolescence: a prospective study. Alcoholism: Clinical and. Experimental Research. 2013; 37(10): 1737–1744. [DOI] [PubMed] [Google Scholar]
  • 60.Kim-Spoon J, Deater-Deckard K, Holmes CJ, Lee JI, Chiu PH, King-Casas B Behavioral and neural inhibitory control moderates the effects of reward sensitivity on adolescent substance use. Neuropsychologia. 2016; 91: 318–326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Strickhouser JE, Terracciano A, Sutin AR. Parent-reported childhood temperament and adolescent self-reported substance use initiation. Addictive Behaviors. 2020; 110: 106503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Quach A, Tervo-Clemmens B, Foran W, Calabro FJ, Chung T, Clark DB, Luna B. Adolescent development of inhibitory control and substance use vulnerability: A longitudinal neuroimaging study. Developmental Cognitive Neuroscience. 2020; 42: 100771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Heitzeg MM, Cope LM, Martz ME, Hardee JE. Neuroimaging risk markers for substance abuse: recent findings on inhibitory control and reward system functioning Current Addiction Reports. 2015; 2, 91–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Courtney KE, Ghahremani DG, Ray LA. Frontostriatal functional connectivity during response inhibition in alcohol dependence. Addiction Biology. 2013; 18(3): 593–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Nixon SJ. Executive functioning among young people in relation to alcohol use. Current Opinions in Psychiatry. 2013; 26(4): 305–309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Dick DM, Agrawal A The genetics of alcohol and other drug dependence. 2008; 31(2); 111–118. [PMC free article] [PubMed] [Google Scholar]
  • 67.Acheson A, Lake SL, Bray BC, Liang Y, Mathias CW, Ryan SR, Charles NE, Dougherty DM Early adolescent trajectories of impulsiveness and sensation seeking in children of fathers with histories of alcohol and other substance use disorders. Alcoholism. 2016; 40:2622–2630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Acheson A Behavioral processes and risk for problem substance use in adolescents. Pharmacology, Biochemistry & Behavior. 2020; 198: 10.1016/j.pbb.2020.173021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.DeVito EE, Meda SA, Jiantonio R, Potenza MN, Krystal JH, Pearlson GD. Neural correlates of impulsivity in healthy males and females with family histories of alcoholism. Neuropsychopharmacology. 2013; 38: 1854–1863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Jones SA, Nagel BJ. Altered frontostriatal white matter microstructure is associated with familial alcoholism and future binge drinking in adolescence. Neuropsychopharmacology. 2020; 44: 1076–1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Cservenka A Neurobiological phenotypes associated with a family history of alcoholism. Drug and Alcohol Dependence. 2016;158:8–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Euser AS, Arends LR, Evans BE, Greaves-Lord K, Huizink AC, et al. The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: a meta-analytic investigation. Neurosci Biobehav Rev. 2012; 36: 572–603. [DOI] [PubMed] [Google Scholar]
  • 73.Squeglia LM, Cservenka A. Adolescence and drug use vulnerability: findings from neuroimaging. Curr Opin Behav Sci. 2017;13:164–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Lees B, Aguinaldo L, Squeglia LM, Infante MA, Wade NE, Hernandez Mejia M, Jacobus J. Parental family history of alcohol use disorder and neural correlates of response inhibition in children from the Adolescent Brain Cognitive Development (ABCD) Study. Alcohol Clin Exp Res. 2020; doi: 10.1111/acer.14343.* This influential study utilized data from the ABCD study Consortium to demonstrate that children with positive family histories of alcohol misuse show deviant patterns of neural activation while completing an fMRI Stop Signal task measure of response inhibition.
  • 75.Kendler KS, Sundquist K, Ohlsson H, Palmer K, Maes H, Winkleby MA, et al. Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study. Archives of General Psychiatry. 2012; 69(7):690–697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ. Family transmission and heritability of externalizing disorders: a twin-family study. Arch. Gen. Psychiatry. 2004;61:922–928. [DOI] [PubMed] [Google Scholar]
  • 77.Friedman NP, Miyake A, Young SE, DeFries JC, Corley RP, Hewitt JK. Individual differences in executive functions are almost entirely genetic in origin. Journal of Experimental Psychology: General. 2008; 137: 201–225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Anokhin AP, Golosheykin S, Grant JD, Heath AC. Heritability of delay discounting in adolescence: a longitudinal twin study. Behav. Genet. 2012; 41(2): 175–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Gustavson DE, Stallings MC, Corley RP, Miyake A, Hewitt JK, Friedman NP. Executive functions and substance use: Relations in late adolescence and early adulthood. Journal of Abnormal Psychology. 2017; 126(2): 257–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Moszczynska A, Callan SP. Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment. J. Pharmacol. Exp. Ther. 2017; 362: 474–488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Sarkar S, Schmued L. Neurotoxicity of Ecstasy (MDMA): An overview. Curr Pharm Biotechnol. 2010;11:460–469. [DOI] [PubMed] [Google Scholar]
  • 82.American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013. [Google Scholar]
  • 83.George O, Koob GF. Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci. Biobehav. Rev., 2010; 35: 232–247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.George O, Mandyam CD, Wee S, Koob GF. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology. 2008;33:2474–2482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Ben-Shahar O, Obara I, Ary AW, Ma N, Mangiardi MA, Medina RL, Szumlinski KK. Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex. Synapse 2009; 63:598–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86,Frazer KM, Richards Q, Keith DR. The long-term effects of cocaine use on cognitive functioning: a systematic critical review. Behav. Brain Res. 2018; 348: 241–262 [DOI] [PubMed] [Google Scholar]
  • 87.Paige KJ, Colder CR. Long-Term effects of early adolescent marijuana use on attentional and inhibitory control. Journal of Studies on Alcohol and Drugs. 2020; 81(2): 164–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Gonzalez R, Pacheco-Colón I, Duperrouzel JC, Hawes SW. Does Cannabis use cause declines in neuropsychological functioning? A Review of longitudinal studies. J Int Neuropsychol Soc JINS. 2017;23:893–902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Becker M, Collins PF, Schultz A, Urosevic S, Schmaling B, Luciana M Longitudinal change in cognition in young adult cannabis users. Journal of Clinical and Experimental Neuropsychology. 2017; doi: 10.1080/13803395.2017.1385729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Jacobus J, Squeglia LM, Infante MA, Castro N, Brumback T, Meruelo AD, Tapert SF. Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal study. Neuropsychology. 2015; 29(6):829–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Ross JM, Ellingson JM, Rhee SH, Hewitt JK, Corley RP, Lessem JM, Friedman NP. Investigating the causal effect of cannabis use on cognitive function with a quasi-experimental co-twin design. Drug and Alcohol Dependence. 2020; 206: 10.1016/j.drugalcdep.2019.10771.** This important longitudinal twin study used a quasi-experimental co-twin design to examine causal effects of cannabis use on cognitive functions, finding little-to-no support for cannabis-induced impairments in executive functions.
  • 92.Khurana A, Romer D, Betancourt LM, Hurt H Working memory ability and early drug use progression as predictors of adolescent substance use disorders. Addiction. 2017; 112 (7): 1220–1228.** This well-designed longitudinal study assessed adolescents across five waves, finding strong evidence that decrements in working memory abilities, measured using well-validated tasks, represent premorbid liabilities for later SUD; working memory did not further decline as a function of the development of an SUD.
  • 93.Boelema SR, Harakeh Z, van Zandvoort MJE, Reijneveld SA, Verhulst FC, Ormel J, et al. Adolescent heavy drinking does not affect maturation of basic executive functioning: Longitudinal findings from the TRAILS study. PloS one. 2015;10(10):e0139186–e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Cutuli D, Ladrón de Guevara-Miranda D, Castilla-Ortega E, Santín LJ, Sampedro-Piquero P Highlighting the role of cognitive and brain reserve in the substance use disorder field. Current Neuropharmacology. 2019; 17: 1056–1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Luciana M, Collins PF, Muetzel RL, Lim KO. Effects of alcohol use initiation on brain structure in typically developing adolescents. American Journal of Drug and Alcohol Abuse. 2013; 39(6): 345–355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Pfefferbaum A, Kwon D, Brumback T, Thompson WK, Cummins K, Tapert SF, Brown SA, Colrain IM, Baker FC, Prouty D, De Bellis MD, Clark DB, Nagel BJ, Chu W, Park SH, Sullivan EV. Altered brain development trajectories in adolescents after initiating drinking. American Journal of Psychiatry. 2018; 175(4): 370–380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Sullivan EV, Brumback T, Tapert SF, Brown SA, Baker FC, Colrain IM, Prouty D, De Bellis MD, Clark DB, Nagel BJ, Pohl KM, Pfefferbaum A. Disturbed cerebellar growth trajectories in adolescents who initiate alcohol drinking. Biological Psychiatry. 2019; 87(7): 632–644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Robert GH, Luo Q, Yu T, Chu C, Ing A, Jia T, et al. Association of gray matter and personality development with Increased drunkenness frequency during adolescence. JAMA Psychiatry. 2019;18:18.* This longitudinal neuroimaging study followed early adolescents enrolled in the IMAGEN Consortium. While participants who subsequently reported substance misuse could be characterized by several deviations in cortical structure, causal Bayesian estimation analyses suggested that many of the observed patterns were attributable to premorbid differences, raising questions about neurotoxicity models of substance misuse.
  • 99.Duperrouzel JC, Granja K, Pacheco-Colón I, Gonzalez R Adverse effects of cannabis use on neurocognitive functioning: A systematic review of meta-analytic studies. Journal of Dual Diagnosis. 2019; 10.1080/15504263.2019.1626030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Brown SA, Brumback T, Tomlinson K, Cummins K, Thompson WK, Nagel BJ, De Bellis MD, Hooper SR, Clark DB, Chung T, Hasler BP, Colrain IM, Baker FB, Prouty D, Pfefferbaum A, Sullivan EV, Pohl KM, Rohlfing T, Nichols BN, Chu W & Tapert SF. (2015). The National Consortium on Alcohol and NeuroDevelopment in Adolescence (NCANDA): A multi-site study of adolescent development and substance use. Journal of Studies on Alcohol and Drugs. 2015; 76:895–908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Feldstein Ewing SW, Bjork JM, Luciana M. (2018). Implications of the ABCD study for developmental neuroscience. Dev Cogn Neurosci. 2018;32:161–164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Kooijman MN, Kruithof CJ, van Duijn CM, Duijts L, Franco OH, van IJzendoorn MH, et al. The Generation R Study: design and cohort update 2017. Eur J Epidemiol. 2016;31(12):1243–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Nixon SJ, Lewis B Cognitive training as a component of treatment of alcohol use disorder: A review. Neuropsychology. 2019; 33(6): 822–841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Romer D Reyna VF, Satterthwaite TD. Beyond stereotypes of adolescent risk taking: Placing the adolescent brain in developmental context. Developmental Cognitive Neuroscience. 2017; 27:19–34. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES